Cion Investment Corp
NYSE:CION
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cion Investment Corp
NYSE:CION
|
US |
|
S
|
Sockets Inc
TSE:3634
|
JP |
|
Sonam Ltd
NSE:SONAMLTD
|
IN |
|
S
|
Sarthak Metals Ltd
NSE:SMLT
|
IN |
|
Accenture PLC
NYSE:ACN
|
IE |
|
Shanghai Film Co Ltd
SSE:601595
|
CN |
|
Arcelik AS
IST:ARCLK.E
|
TR |
|
Y
|
Yantai North Andre Juice Co Ltd
SSE:605198
|
CN |
|
Amazia Inc
TSE:4424
|
JP |
|
Yamazaki Baking Co Ltd
TSE:2212
|
JP |
|
I
|
Integrated Design & Engineering Holdings Co Ltd
TSE:9161
|
JP |
|
Willow Biosciences Inc
TSX:WLLW
|
CA |
|
C
|
Ching Feng Home Fashions Co Ltd
TWSE:9935
|
TW |
|
Shoulder Innovations Inc
NYSE:SI
|
US |
|
Qingdao Haier Biomedical Co Ltd
SSE:688139
|
CN |
|
A
|
Arctic Blue Beverages AB
STO:ARCTIC
|
SE |
Balance Sheet
Balance Sheet Decomposition
Cion Investment Corp
Cion Investment Corp
Balance Sheet
Cion Investment Corp
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
18
|
6
|
20
|
4
|
83
|
8
|
8
|
8
|
|
| Cash |
18
|
6
|
20
|
4
|
83
|
8
|
8
|
8
|
|
| Total Receivables |
6
|
23
|
6
|
3
|
2
|
1
|
3
|
4
|
|
| Accounts Receivables |
6
|
20
|
6
|
3
|
2
|
1
|
3
|
4
|
|
| Other Receivables |
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
2
|
1
|
1
|
1
|
1
|
2
|
|
| Total Current Assets |
24
|
30
|
28
|
7
|
86
|
11
|
12
|
14
|
|
| Note Receivable |
18
|
15
|
18
|
22
|
27
|
37
|
45
|
28
|
|
| Long-Term Investments |
1 865
|
1 765
|
1 569
|
1 754
|
1 760
|
1 954
|
1 889
|
1 813
|
|
| Total Assets |
1 907
N/A
|
1 810
-5%
|
1 615
-11%
|
1 783
+10%
|
1 872
+5%
|
2 002
+7%
|
1 946
-3%
|
1 855
-5%
|
|
| Liabilities | |||||||||
| Accounts Payable |
18
|
2
|
1
|
13
|
1
|
6
|
2
|
3
|
|
| Accrued Liabilities |
17
|
19
|
16
|
17
|
22
|
24
|
21
|
18
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
15
|
11
|
3
|
0
|
|
| Total Current Liabilities |
35
|
21
|
17
|
30
|
37
|
40
|
26
|
22
|
|
| Long-Term Debt |
893
|
837
|
720
|
822
|
951
|
1 082
|
1 099
|
1 126
|
|
| Total Liabilities |
927
N/A
|
858
-7%
|
737
-14%
|
852
+16%
|
989
+16%
|
1 122
+13%
|
1 125
+0%
|
1 147
+2%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
70
|
103
|
177
|
130
|
161
|
154
|
201
|
297
|
|
| Additional Paid In Capital |
1 049
|
1 055
|
1 055
|
1 060
|
1 045
|
1 033
|
1 022
|
1 004
|
|
| Total Equity |
979
N/A
|
953
-3%
|
878
-8%
|
931
+6%
|
884
-5%
|
880
0%
|
821
-7%
|
708
-14%
|
|
| Total Liabilities & Equity |
1 907
N/A
|
1 810
-5%
|
1 615
-11%
|
1 783
+10%
|
1 872
+5%
|
2 002
+7%
|
1 946
-3%
|
1 855
-5%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
56
|
57
|
57
|
57
|
55
|
54
|
53
|
51
|
|